This news is pretty good.
It fixes the Debt to Equity.
Hopefully it gets rid of the pay day lender.
The money is being provided by the state where the university did the research.
It's good recognition that the SP drop was all a bit of a panic.
We now have multiple collaborations with well funded partners.
The notion that the lung fibrosis treatment is much better as an inhaler now seems reasonable and obvious.
I think 1AD is being forgiven for having taken the hard decisions and retail investors are buying back in.
Let's hope we can steadily get back to 20c before the end of October.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.782M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 9758466 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 15470189 | 19 |
View Market Depth
| Last trade - 16.21pm 01/08/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |
Day chart unavailable